A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura

Richard B Lipton1 The Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Sciences, Department of Epidemiology & Population Health, Albert Einstein College of Medicine and Montefiore Headache Center, New York, NY, USA

https://orcid.org/0000-0003-2652-2897 View further author information

Sagar Munjal2 Operations & Medical Affairs Proprietary Products, Dr. Reddy’s Laboratories Inc., Princeton, NJ, USACorrespondence[email protected]

https://orcid.org/0000-0001-5387-720X View further author information

Stewart J Tepper3 Geisel School of Medicine, Dartmouth College, Lebanon, NH, USAView further author information

Charlie Iaconangelo4 Pharmerit - An Open Health Company, Bethesda, MD, USAView further author information

Daniel Serrano4 Pharmerit - An Open Health Company, Bethesda, MD, USAView further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date